Whitehawk Therapeutics (WHWK) Gross Profit: 2018-2025
Historic Gross Profit for Whitehawk Therapeutics (WHWK) over the last 4 years, with Mar 2025 value amounting to $6.4 million.
- Whitehawk Therapeutics' Gross Profit rose 35.82% to $6.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $24.6 million, marking a year-over-year increase of 17.86%. This contributed to the annual value of $23.0 million for FY2024, which is 6.56% up from last year.
- As of Q1 2025, Whitehawk Therapeutics' Gross Profit stood at $6.4 million, which was down 0.99% from $6.4 million recorded in Q4 2024.
- In the past 5 years, Whitehawk Therapeutics' Gross Profit ranged from a high of $14.0 million in Q4 2021 and a low of -$227,000 during Q2 2021.
- In the last 3 years, Whitehawk Therapeutics' Gross Profit had a median value of $5.4 million in 2024 and averaged $5.7 million.
- Per our database at Business Quant, Whitehawk Therapeutics' Gross Profit slumped by 167.97% in 2021 and then skyrocketed by 2,426.11% in 2022.
- Quarterly analysis of 5 years shows Whitehawk Therapeutics' Gross Profit stood at $14.0 million in 2021, then plummeted by 64.25% to $5.0 million in 2022, then grew by 7.87% to $5.4 million in 2023, then rose by 19.45% to $6.4 million in 2024, then surged by 35.82% to $6.4 million in 2025.
- Its last three reported values are $6.4 million in Q1 2025, $6.4 million for Q4 2024, and $6.4 million during Q3 2024.